The Latest

• August 27, 2021

  By Charleston Lim

  FDA Bans Sale Of First Flavored E-Cig Product Batch, Cites Youth Health Threat

  The FDA said it is still reviewing million of marketing applications, which could lead to more bans.

  

  The FDA said it is still reviewing million of marketing applications, which could lead to more bans.
• August 30, 2020

  By Artie Villasanta

  Remdesivir Use Expanded To Include Patients With Suspected COVID-19

  The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19.

  

  The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19.